The gene regulation of lipid metabolism by peroxisome proliferator-activated receptor alpha (RPARalpha) has been reported to be a candidate in prostate cancer development, that function by regulating gene expression through DNA methylation (Yang et al., 2013). Here, PPARA is linked to prostate carcinoma.